about
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific RegionAEG-1/MTDH/LYRIC in liver cancerEmerging trends in hepatocellular carcinoma: focus on diagnosis and therapeuticsRole of stereotactic body radiation therapy for hepatocellular carcinomaComparison of hepatocellular carcinoma in Eastern versus Western populations.Risk prediction models for hepatocellular carcinoma in different populations.What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient.Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trialRisk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapiesRisk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors.Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significanceBody mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversionKIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection.Oncogenic potential of hepatitis C virus proteinsHepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.Hepatocellular carcinoma in Asia: Prevention strategy and planning.Hepatocellular carcinoma: focus on different aspects of managementDosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinomaEfficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysis.Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.Surveillance and Diagnosis of Hepatocellular Carcinoma.Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancerThe Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.Status of primary liver cancer found through routine health check-up.Liver transplantation for hepatocellular carcinoma: the Japanese experience.The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyHealth utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trialsOutcome of hepatectomy for hepatocellular carcinoma in elderly patients with portal hypertension.Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.
P2860
Q26750444-C0DEAEA4-F3BB-4DD0-A1E2-80F00333D8BAQ26822570-6A6E2902-4D23-424B-A82F-10FE5FF00AB0Q26851272-CEB504A5-7EC5-4437-BA44-E661CF49CBAFQ26864969-96B975DD-2E55-45DE-96F5-03FEFC22E8EDQ30245396-20BE35F3-BACD-4AF3-B382-4A0A06AC0E63Q30383460-64CD7927-6D50-43DF-A3FB-3107ACA22FE2Q30908529-C8A8942D-6A10-4E35-B363-671351733650Q31138183-55340324-4785-41E0-ACF4-B00C1D38EE57Q33601691-854FA307-1202-43E3-8F99-2596CA7DCDB0Q33818746-B8E3C695-ED3D-4E2B-AA9D-4B1FFF590309Q33885985-6C6B8CD0-6498-43A2-8869-502F62D00BE7Q33895113-3144F8B4-6FB8-4357-8ADE-E1C6ACA13412Q33977173-18B90FA1-2416-4D93-8C29-97B13BACD067Q34168643-7A514F29-6DDA-4370-8A40-08C2447C7353Q34381391-62B22A12-D733-463D-89CE-580A9F360E75Q34513827-C10A8516-73F3-4C2A-8820-59A329A992A2Q34606618-B8390F01-A84D-4216-AB07-98B1A1B7E4A3Q34635064-397A06B9-03D5-4C88-B3C7-484173C2C416Q34932600-8BE63EE2-70D4-44FF-99C0-B976DFF42F13Q35070933-1EEF05DF-E57A-4033-A392-98CDEB9024BFQ35085706-2AB5A738-64E7-44E7-A38F-14083738B553Q35261292-AE8B7BF0-9421-42F2-85DA-0D76DC1CAC15Q35552046-AC90C02B-AA98-441E-B248-63F03FC39375Q35790424-62D54BF4-FAD9-47BD-BAD3-DE327BAD7E78Q35986436-62509622-62D3-43D3-A19A-C91D30B0728FQ36071172-2FB4192A-8853-4CED-8F93-37CDF2194483Q36210228-99B7245F-F111-4414-8D3D-6F6A384DA923Q36770533-CAD2673B-3B8C-4CC4-92EC-517C092CDA57Q36812480-9B3BC28E-0CB7-44B4-8AA8-EC7829527011Q36812745-7CF1F0CF-ABDD-497B-AC0F-D99F0E88B9BFQ36848551-44B521EC-FFE1-4641-9902-5D4994677B45Q37124700-6AFABDC0-D3F9-4D34-97EA-422186F173BAQ37220457-8EB8E288-C12A-4A52-B23A-32833F74117EQ37599388-B81C227F-5FFA-4EE1-99C3-B4FB56DE8B87Q37606028-054BA7E1-73B3-45F3-874B-425B2A36BF61Q37615658-3AB76966-E52C-415D-97AA-0E40AA7547EDQ37670901-5ED768B5-EA6E-4D3A-9456-94DA3F2F8FA6Q37726632-A22CCE0E-51B5-42D1-97D0-29935990F41AQ37932057-CD5EAFB0-0943-479E-ACB1-AC4072AA0F5BQ38046452-D47232B0-E462-4A72-B254-EAA941C0395A
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Epidemiology of hepatocellular carcinoma in Japan.
@en
type
label
Epidemiology of hepatocellular carcinoma in Japan.
@en
prefLabel
Epidemiology of hepatocellular carcinoma in Japan.
@en
P2093
P1476
Epidemiology of hepatocellular carcinoma in Japan.
@en
P2093
Eiji Tanaka
Kaname Yoshizawa
Kendo Kiyosawa
Tetsuya Ichijo
P304
P356
10.1007/S00535-008-2251-0
P478
44 Suppl 19
P577
2009-01-16T00:00:00Z